Yipinhong Pharmaceutical Co Ltd Class A
ApicHope Pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of pharmaceutical drugs in China. The company offers pediatric medicines, such as fuganlin and yiqi jianpi oral liquids, carboxymestrine oral solutions, and xiao'er kechuanling oral liquid products; and clindamycin palmitate hydrochloride dispersible tablets, acetylkitasamycin for suspension, qinxia… Read more
Yipinhong Pharmaceutical Co Ltd Class A (300723) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.008x
Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) has a cash flow conversion efficiency ratio of 0.008x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥14.81 Million) by net assets (CN¥1.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yipinhong Pharmaceutical Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yipinhong Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yipinhong Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tsakos Energy Navigation Ltd
NYSE:TEN
|
0.046x |
|
Modern Times Group Mtg AB
ST:MTG-B
|
0.079x |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
-0.071x |
|
Xinhuanet Co Ltd
SHG:603888
|
0.034x |
|
ShenZhen Kondarl Group Co Ltd
SHE:000048
|
0.050x |
|
John B Sanfilippo & Son Inc
NASDAQ:JBSS
|
0.169x |
|
American Public Education Inc
NASDAQ:APEI
|
0.078x |
|
Zehnder
SW:ZEHN
|
0.213x |
Annual Cash Flow Conversion Efficiency for Yipinhong Pharmaceutical Co Ltd Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.94 Billion | CN¥-550.42 Million | -0.284x | -261.26% |
| 2023-12-31 | CN¥2.60 Billion | CN¥458.05 Million | 0.176x | -19.70% |
| 2022-12-31 | CN¥2.17 Billion | CN¥475.53 Million | 0.220x | +1.16% |
| 2021-12-31 | CN¥2.02 Billion | CN¥438.10 Million | 0.217x | +17.91% |
| 2020-12-31 | CN¥1.50 Billion | CN¥275.22 Million | 0.184x | -12.06% |
| 2019-12-31 | CN¥1.34 Billion | CN¥280.65 Million | 0.209x | +14.00% |
| 2018-12-31 | CN¥1.30 Billion | CN¥238.60 Million | 0.184x | +44.01% |
| 2017-12-31 | CN¥1.11 Billion | CN¥141.35 Million | 0.128x | -70.61% |
| 2016-12-31 | CN¥336.50 Million | CN¥146.01 Million | 0.434x | +152.00% |
| 2015-12-31 | CN¥200.66 Million | CN¥34.55 Million | 0.172x | +151.17% |
| 2014-12-31 | CN¥127.52 Million | CN¥8.74 Million | 0.069x | -90.62% |
| 2013-12-31 | CN¥185.61 Million | CN¥135.68 Million | 0.731x | -- |